SCHEMBL7988684

SCHEMBL7988684

Cc1ccc(-c2[nH]c(C)nc2C(=O)Nc2nccs2)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.59
NPC1 O15118 5/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
GAA P10253 2/20 0.55
MGAM O43451 1/20 0.55
SI P14410 1/20 0.55
MGAM2 Q2M2H8 1/20 0.55
POLB P06746 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
PPARG P37231 1/20 0.49
NCOR2 Q9Y618 1/20 0.49
MEN1 O00255 1/20 0.48
MAPT P10636 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 1/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7992238 0.86 RAB9A (0.54) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7977513 0.85 MEN1 (0.54) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7995070 0.85 MEN1 (0.54) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7977950 0.85 MAPT (0.53) RAB9ANPC1SMN1; SMN2GAAMGAM
Hydrochloric Acid SCHEMBL7977943 0.85 MEN1 (0.53) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7988571 0.83 MAPT (0.55) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7989403 0.83 AURKA (0.51) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7992083 0.82 RAB9A (0.50) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7977884 0.82 SIRT2 (0.56) RAB9ANPC1SMN1; SMN2GAAMGAM
SCHEMBL7995205 0.82 RAB9A (0.49) RAB9ANPC1SMN1; SMN2GAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288061-B1 INTERLEUKIN INHIBITORS; ASTHMA, BRONCHODILATOR AGENTS, ANTIALLERGENS WELFIDE CORPORATION (JP) 2001-09-11 US disclosed